Evidence map›Paper›PMID 35215931›Full record

ArticleViruses2022

Full Genome of batCoV/MinFul/2018/SriLanka, a Novel Alpha-Coronavirus Detected in

Therese Muzeniek, Thejanee Perera, Sahan Siriwardana, Dilara Bas, Fatimanur Kaplan, Mizgin Öruc, Beate Becker-Ziaja, Inoka Perera, Jagathpriya Weerasena, Shiroma Handunnetti and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Paramyxovirus Diversity within One Population ofPathogens (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Therese MuzeniekCentre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0003-4429-1738
Thejanee PereraInstitute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, Colombo 00300, Sri Lanka.ORCID 0000-0002-4667-6466
Sahan SiriwardanaIDEA (Identification of Emerging Agents) Laboratory, Department of Zoology and Environment Sciences, University of Colombo, Colombo 00300, Sri Lanka.
Dilara BasCentre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, 13353 Berlin, Germany.
Fatimanur KaplanCentre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, 13353 Berlin, Germany.
Mizgin ÖrucCentre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, 13353 Berlin, Germany.
Beate Becker-ZiajaCentre for International Health Protection, Public Health Laboratory Support (ZIG 4), Robert Koch Institute, 13353 Berlin, Germany.
Inoka PereraIDEA (Identification of Emerging Agents) Laboratory, Department of Zoology and Environment Sciences, University of Colombo, Colombo 00300, Sri Lanka.
Jagathpriya WeerasenaInstitute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, Colombo 00300, Sri Lanka.
Shiroma HandunnettiInstitute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, Colombo 00300, Sri Lanka.
Franziska SchwarzCentre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0003-3848-9422
Gayani PremawansaColombo North Teaching Hospital, Ragama 11010, Sri Lanka.
Sunil PremawansaIDEA (Identification of Emerging Agents) Laboratory, Department of Zoology and Environment Sciences, University of Colombo, Colombo 00300, Sri Lanka.
Wipula YapaIDEA (Identification of Emerging Agents) Laboratory, Department of Zoology and Environment Sciences, University of Colombo, Colombo 00300, Sri Lanka.
Andreas NitscheCentre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0001-8185-3176
Claudia KohlCentre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0002-1480-8911
Robert Koch Institute · DEUniversity of Colombo · LKColombo North Teaching Hospital · LK

Funding

Bundesministerium für Gesundheit Global Health Protection Programme
6 · The paper itself

Abstract

Coronaviruses (CoV) are divided into the genera α-CoVs, β-CoVs, γ-CoVs and δ-CoVs. Of these, α-CoVs and β-CoVs are solely capable of causing infections in humans, resulting in mild to severe respiratory symptoms. Bats have been identified as natural reservoir hosts for CoVs belonging to these two genera. Consequently, research on bat populations, CoV prevalence in bats and genetic characterization of bat CoVs is of special interest to investigate the potential transmission risks. We present the genome sequence of a novel α-CoV strain detected in rectal swab samples of

Indexed as

Genome, ViralAlphacoronavirusAnimalsCavesChiropteraCoronavirus InfectionsDisease ReservoirsEvolution, MolecularFemaleMalePhylogenySequence Analysis, DNASri Lankabat alphacoronaviruscave-dwellingcoronavirusfull genomeMiniopterus fuliginosusone healthSri Lankasympatric colony

Identifiers

PMID35215931
PMCPMC8874963
OpenAlexW4210945913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.